NCT02501538View on ClinicalTrials.gov

Continuous Diffusion of Oxygen (CDO) Treatment for Healing of Diabetic Foot Ulcers

NACompletedINTERVENTIONAL
Enrollment

23

Participants

Timeline

Start Date

June 30, 2015

Primary Completion Date

January 10, 2019

Study Completion Date

January 10, 2020

Conditions
Foot Ulcer, Diabetic
Interventions
DEVICE

Transcutaneous O2 device

A portable device that delivers continuous diffusion of oxygen.

Trial Locations (1)

75390

UT Southwestern Medical Center at Dallas, Dallas

All Listed Sponsors
lead

University of Texas Southwestern Medical Center

OTHER

NCT02501538 - Continuous Diffusion of Oxygen (CDO) Treatment for Healing of Diabetic Foot Ulcers | Biotech Hunter | Biotech Hunter